How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/supplementation-of-subpotent-anesthetic-agents-during-maintenance-of-anesthesia-for-short-operative-procedures.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Supplementation of subpotent anesthetic agents during maintenance of anesthesia for short operative procedures — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Supplementation of subpotent anesthetic agents during maintenance of anesthesia for short operative procedures (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Supplementation of subpotent anesthetic agents during maintenance of anesthesia for short operative procedures, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Amidate	Etomidate	Pfizer Inc.	General Anesthetic [EPC]	GABA A receptor alpha-2/beta-2/gamma-2

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer Inc. · 1 drug in Supplementation of subpotent anesthetic agents during maintenance of anesthesia for short operative procedures

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Supplementation of subpotent anesthetic agents during maintenance of anesthesia for short operative procedures:

Cite this brief

Drug Landscape (2026). Supplementation of subpotent anesthetic agents during maintenance of anesthesia for short operative procedures — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/supplementation-of-subpotent-anesthetic-agents-during-maintenance-of-anesthesia-for-short-operative-procedures. Accessed 2026-06-10.

Supplementation of subpotent anesthetic agents during maintenance of anesthesia for short operative procedures full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing